Gene · 442906
Papers1,644
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,644
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL. | Leukemia | 2023 | 37169950 | PubTator, text mining | PubMed |
| Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression. | Epigenetics | 2023 | 37166441 | PubTator, text mining | PubMed |
| Exosomes and circular RNAs: promising partners in hepatocellular carcinoma from bench to bedside. | Discov Oncol | 2023 | 37154831 | PubTator, text mining | PubMed |
| It takes two to remyelinate: A bioengineered platform to study astrocyte-oligodendrocyte crosstalk and potential therapeutic targets in remyelination. | Biomater Adv | 2023 | 37148597 | PubTator, text mining | PubMed |
| Serum microRNAs associated with concussion in football players. | Front Neurol | 2023 | 37144000 | PubTator, text mining | PubMed |
| Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. | Front Oncol | 2023 | 37124518 | PubTator, text mining | PubMed |
| Circular RNA EPHA3 suppresses progression and metastasis in prostate cancer through the miR-513a-3p/BMP2 axis. | J Transl Med | 2023 | 37118847 | PubTator, text mining | PubMed |
| Aberrant Expression of FGFRL1 in Esophageal Cancer and Its Regulation by miR-107. | Asian Pac J Cancer Prev | 2023 | 37116156 | PubTator, text mining | PubMed |
| miRNA implication in the pathogenesis and the outcome of Tunisian endemic pemphigus foliaceus. | Exp Dermatol | 2023 | 37114366 | PubTator, text mining | PubMed |
| Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma. | Clin Cancer Res | 2023 | 37093199 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson's Disease via Bioinformatics Analysis. | Parkinsons Dis | 2023 | 37089789 | PubTator, text mining | PubMed |
| Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration. | Int J Gen Med | 2023 | 37077765 | PubTator, text mining | PubMed |
| Circ_RBM23 knockdown suppresses chemoresistance, proliferation, migration and invasion of sorafenib-resistant HCC cells through miR-338-3p/RAB1B axis. | Pathol Res Pract | 2023 | 37075641 | PubTator, text mining | PubMed |
| Expression and molecular regulation of non-coding RNAs in HPV-positive head and neck squamous cell carcinoma. | Front Oncol | 2023 | 37064141 | PubTator, text mining | PubMed |
| The estrogen/miR-338-3p/ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function. | Environ Toxicol | 2023 | 37052432 | PubTator, text mining | PubMed |
| Identifying Key Regulators of Keratinization in Lung Squamous Cell Cancer Using Integrated TCGA Analysis. | Cancers (Basel) | 2023 | 37046726 | PubTator, text mining | PubMed |
| Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges. | Acta Neuropathol | 2023 | 37012443 | PubTator, text mining | PubMed |
| Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma. | Front Genet | 2023 | 36999053 | PubTator, text mining | PubMed |
| Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease. | Front Cardiovasc Med | 2023 | 36998978 | PubTator, text mining | PubMed |
| Recent advances in the crosstalk between adipose, muscle and bone tissues in fish. | Front Endocrinol (Lausanne) | 2023 | 36998471 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442906/papers?page=6